MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strakhova, M. I.
Right arrow Articles by Skolnick, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strakhova, M. I.
Right arrow Articles by Skolnick, P.

Vol. 58, Issue 6, 1434-1440, December 2000

A Single Amino Acid Residue on the alpha 5 Subunit (Ile215) Is Essential for Ligand Selectivity at alpha 5beta 3gamma 2 gamma -Aminobutyric AcidA Receptors

Marina I. Strakhova,1 Scott C. Harvey, Christine M. Cook, James M. Cook, and Phil Skolnick

Neuroscience Discovery Research, Lilly Research Laboratories, Indianapolis, Indiana (M.I.S., S.C.H., C.M.C., P.S.); Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana (C.M.C., P.S.); and Department of Chemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (J.M.C.)

Imidazobenzodiazepines such as RY-80 have been reported to exhibit both high affinity and selectivity for GABAA receptors containing an alpha 5 subunit. A single amino acid residue (alpha 5Ile215) has been identified that plays a critical role in the high-affinity, subtype-selective effects of RY-80 and structurally related ligands. Thus, substitution of alpha 5Ile215 with the cognate amino acid contained in the alpha 1 subunit (Val211) reduced the selectivity of RY-80 for alpha 5beta 3gamma 2 receptors from ~135- to ~8-fold compared with alpha 1beta 3gamma 2 receptors. This mutation produced a comparable reduction in the selectivity of RY-24 (a structural analog of RY-80) for alpha 5beta 3gamma 2 receptors but did not markedly alter the affinities of ligands (e.g., flunitrazepam) that are not subtype-selective. Conversely, substitution of the alpha 1 subunit with the cognate amino acid contained in the alpha 5 subunit (i.e., alpha 1V211I) increased the affinities of alpha 5-selective ligands by a ~20-fold and reduced by 3-fold the affinity of an alpha 1-selective agonist (zolpidem). Increasing the lipophilicity (e.g., by substitution of Phe) of alpha 5215 did not significantly affect the affinities (and selectivities) of RY-80 and RY-24 for alpha 5-containing GABAA receptors. However, the effect of introducing hydrophilic and or charged residues (e.g., Lys, Asp, Thr) at this position was no greater than that produced by the alpha 5I215V mutation. These data indicate that residue alpha 5215 may not participate in formation of the lipophilic L2 pocket that has been proposed to contribute to the unique pharmacological properties of alpha 5-containing GABAA receptors. RY-80 and RY-24 acted as inverse agonists in both wild-type alpha 5beta 3gamma 2 and mutant alpha 5I215Kbeta 3gamma 2 receptors expressed in Xenopus laevis oocytes. However, both RY-24 and RY-80 acted as antagonists at mutant alpha 5I215Vbeta 3gamma 2 and alpha 5I215Tbeta 3gamma 2 receptors, whereas the efficacy of flunitrazepam was similar at all three receptor isoforms. The data demonstrate that amino acid residue alpha 5215 is a determinant of both ligand affinity and efficacy at GABAA receptors containing an alpha 5 subunit.


1 Current address: Thermogen, Inc., 2225 W. Harrison Street, Chicago, IL 60521.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
R. T. Robinson, B. C. Drafts, and J. L. Fisher
Fluoxetine Increases GABAA Receptor Activity through a Novel Modulatory Site
J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 978 - 984.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. W. Sawyer, D. C. Chiara, R. W. Olsen, and J. B. Cohen
Identification of the Bovine gamma -Aminobutyric Acid Type A Receptor alpha Subunit Residues Photolabeled by the Imidazobenzodiazepine [3H]Ro15-4513
J. Biol. Chem., December 13, 2002; 277(51): 50036 - 50045.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics